KCT0012374招募中不适用
Utility Assessment of Patients Receiving Korean Medicine for Alzheimer's Disease, Parkinson's Disease, and Hemiplegia in Long-term Care Hospitals: A Multicenter Observational Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort, Time Perspective : Prospective, Enrollment : 240, Biospecimen Retention : Not collect nor Archive
入排标准
- 年龄范围
- 19(Year) 至 No Limit（—）
- 性别
- All
入选标准
- •(1) Inpatients currently admitted to a long-term care hospital
- •(2) Able to communicate, or able to be assessed through a primary caregiver or legal guardian
- •(3) Have voluntarily provided written informed consent for study participation, either personally or through a legal representative
- •(4) Meet one of the following disease-specific criteria (a single participant cannot be enrolled under more than one disease category):
- •Alzheimer's disease
- •Diagnosed with F00 (Dementia in Alzheimer's disease) or its subcategories, or G30 (Alzheimer's disease) or its subcategories
- •Moderate severity: Clinical Dementia Rating (CDR) of 0.5 or 1, and classified as "Medical Moderate" under the Korean long-term care hospital inpatient classification system; Severe severity: CDR of 2 or 3, and classified as "Medical High" under the same classification system
- •Parkinson's disease
- •Diagnosed with G20 (Parkinson's disease), G21 (Secondary parkinsonism) or its subcategories, G22 (Parkinsonism in diseases classified elsewhere), G23.2 (Multiple system atrophy, parkinsonian type), or F02.3 (Dementia in Parkinson's disease)
- •Moderate severity: Hoehn & Yahr (H-Y) scale 1, 2, or 3, and classified as "Medical Moderate" under the Korean long-term care hospital inpatient classification system;
- •Severe severity: H-Y scale 4 or 5, and classified as "Medical High" under the same classification system
- •Hemiplegia
- •Diagnosed with G81 (Hemiplegia) or its subcategories
- •Admitted to a long-term care hospital after completing acute-phase treatment for stroke, with onset between 3 months and 2 years prior to enrollment
- •Moderate severity: classified as "Medical Moderate" under the Korean long-term care hospital inpatient classification system; Severe severity: classified as "Medical High" under the same classification system
- •(5) Meet one of the following treatment group allocation criteria:
- •Korean medicine treatment group: Receiving two or more types of Korean medicine treatment (among acupuncture, electroacupuncture, moxibustion, and cupping) regularly (at least twice a week) for two months or longer during hospitalization
- •Conventional treatment group: Not receiving any Korean medicine treatment during the current hospitalization (including those with a past history of Korean medicine treatment but no such treatment since admission)
排除标准
- •(1) Scheduled to be transferred or discharged before completion of informed consent and data collection
- •(2) Judged to be unable to undergo study assessments due to uncontrolled severe comorbidities (e.g., cardiovascular, respiratory, or infectious diseases)
- •(3) Currently participating in another clinical study for the same disease
- •(4) Judged by the principal investigator or designated researcher to be unsuitable for participation in the study for any other reason
研究者
相似试验
尚未招募
不适用
Evaluation of the Efficacy, Safety, and Patient Self-Assessment in Reducing Downtime by Use of Membrane Formation Collagen Hydrogel Following Ablative CO2 Fractional Laser ResurfacingN/A, healthy people.jRCT10702501175
进行中（未招募）
2 期
To Study effect of Gayatriyadi kasayam with Chandraprabha vati in the management of Diabetic patientsCTRI/2026/07/114062Sonu Yadav37
进行中（未招募）
不适用
Comparison of Hyaluronic Acid Gel and Laser Therapy Along with Deep Cleaning for the Treatment of Gum DiseaseCTRI/2026/07/113812Sudipa Garai148
进行中（未招募）
3 期
NN9838-7910: A research study to look at how two different doses of CagriSema and one dose of semaglutide help people living with obesity with or without type 2 diabetes lose weightNutritional, Metabolic, EndocrinePACTR202607641626021Novo Nordisk120
进行中（未招募）
Unknown
Effectiveness of OjasNoor Renewal Serum for BrighteningCTRI/2026/07/114186VedaLume Private Limited, OjasNoor36